Stem cells in the treatment of neurodegenerative diseases: references

References to the article by Dantuma et al.
Stem cells for the treatment of neurodegenerative diseases
(Stem cells in the treatment of neurodegenerative diseases)

1. Ehnert S, Glanemann M, Schmitt A, Vogt S, Shanny N, Nussler NC, Stockle U, Nussler A: The possible use of stem cells in regenerative medicine: dream or reality? Langenbecks Arch Surg 2009, 394:985-997.
2. Becker AJ, McCulloch EA, Till JE: Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 1963, 197:452-454.
3. Siminovitch L, McCulloch EA, Till JE: The distribution of colony-forming cells among spleen colonies. J Cell Physiol 1963, 62:327-336.
4. Mimeault M, Hauke R, Batra SK: Stem cells: a revolution in therapeutics- recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 2007, 82:252-264.
5. Juengst E, Fossel M: The ethics of embryonic stem cells--now and forever, cells without end. JAMA 2000, 284:3180-3184.
6. McLaren A: Ethical and social considerations of stem cell research. Nature 2001, 414:129-131.
7. Li JY, Christophersen NS, Hall V, Soulet D, Brundin P: Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci 2008, 31:146-153.
8. Mimeault M, Batra SK: Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells 2006, 24:2319-2345.
9. Eminli S, Utikal J, Arnold K, Jaenisch R, Hochedlinger K: Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 2008, 26:2467-2474.
10. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, Plath K: Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 2008, 105:2883-2888.
11. Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
12. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324.
13. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, Melton DA: Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008, 26:795-797.
14. Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Arauzo-Bravo MJ, Ruau D, Han DW, Zenke M, Scholer HR: Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008, 454:646-650.
15. Rolletschek A, Wobus AM: Induced human pluripotent stem cells: promises and open questions. Biol Chem 2009, 390:845-849.
16. Yamanaka S: A fresh look at iPS cells. Cell 2009, 137:13-17.
17. Marion RM, Strati K, Li H, Murga M, Blanco R, Ortega S, Fernandez-Capetillo O, Serrano M, Blasco MA: A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009, 460:1149-1153.
18. Jia F, Wilson KD, Sun N, Gupta DM, Huang M, Li Z, Panetta NJ, Chen ZY, Robbins RC, Kay MA, Longaker MT, Wu JC: A nonviral minicircle vector for deriving human iPS cells. Nat Methods 2010, 7:197-199.
19. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R: Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136:964-977.
20. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y, Siuzdak G, Scholer HR, Duan L, Ding S: Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4:381-384.
21. Zhongling F, Gang Z, Lei Y: Neural stem cells and Alzheimer’s disease: challenges and hope. Am J Alzheimers Dis Other Demen 2009, 24:52-57.
22. Ma DK, Bonaguidi MA, Ming GL, Song H: Adult neural stem cells in the mammalian central nervous system. Cell Res 2009, 19:672-682.
23. Limke TL, Rao MS: Neural stem cells in aging and disease. J Cell Mol Med 2002, 6:475-496.
24. Zhao C, Deng W, Gage FH: Mechanisms and functional implications of adult neurogenesis. Cell 2008, 132:645-660.
25. Qu T, Brannen CL, Kim HM, Sugaya K: Human neural stem cells improve cognitive function of aged brain. Neuroreport 2001, 12:1127-1132.
26. Alzheimer’s Association: 2010 Alzheimer’s disease facts and figures. Alzheimers Dement 2010, 6:158-194.
27. Waldau B, Shetty AK: Behavior of neural stem cells in the Alzheimer brain. Cell Mol Life Sci 2008, 65:2372-2384.
28. Xuan AG, Luo M, Ji WD, Long DH: Effects of engrafted neural stem cells in
Alzheimer’s disease rats. Neurosci Lett 2009, 450:167-171.
29. Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Muller FJ, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM: Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A 2009, 106:13594-13599.
30. Boucherie C, Hermans E: Adult stem cell therapies for neurological disorders: benefits beyond neuronal replacement? J Neurosci Res 2009, 87:1509-1521.
31. Kim SU, de Vellis J: Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res 2009, 87:2183-2200.
32. Thinakaran G, Koo EH: Amyloid precursor protein trafficking, processing, and function. J Biol Chem 2008, 283:29615-29619.
33. Roberson ED, Mucke L: 100 years and counting: prospects for defeating Alzheimer’s disease. Science 2006, 314:781-784.
34. Lee HG, Casadesus G, Zhu X, Castellani RJ, McShea A, Perry G, Petersen RB, Bajic V, Smith MA: Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer’s disease. Neurochem Int 2009, 54:84-88.
35. Park DH, Eve DJ, Chung YG, Sanberg PR: Regenerative medicine for neurological disorders. ScientificWorldJournal 2010, 10:470-489.
36. Hampel H, Broich K: Enrichment of MCI and early Alzheimer’s disease treatment trials using neurochemical and imaging candidate biomarkers. J Nutr Health Aging 2009, 13:373-375.
37. Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H, Hagman G, Larksater M, Winblad B, Zetterberg H, Blennow K, Langstrom B, Nordberg A: Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer’s disease. Ann Neurol 2008, 63:621-631.
38. Maggini M, Vanacore N, Raschetti R: Cholinesterase inhibitors: drugs looking for a disease? PLoS Med 2006, 3:e140.
39. Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M: Brain-derived neurotrophic factor is reduced in Alzheimer’s disease. Brain Res Mol Brain Res 1997, 49:71-81.
40. Sugaya K, Kwak YD, Ohmitsu O, Marutle A, Greig NH, Choumrina E: Practical issues in stem cell therapy for Alzheimer’s disease. Curr Alzheimer Res 2007, 4:370-377.
41. Vrotsos EG, Sugaya K: MCP-1-induced migration of NT2 neuroprogenitor cells involving APP signaling. Cell Mol Neurobiol 2009, 29:373-381.
42. Marutle A, Ohmitsu M, Nilbratt M, Greig NH, Nordberg A, Sugaya K: Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine. Proc Natl Acad Sci U S A 2007, 104:12506-12511.
43. Kwak YD, Brannen CL, Qu T, Kim HM, Dong X, Soba P, Majumdar A, Kaplan A, Beyreuther K, Sugaya K: Amyloid precursor protein regulates differentiation of human neural stem cells. Stem Cells Dev 2006, 15:381-389.
44. Lu P, Jones LL, Snyder EY, Tuszynski MH: Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003, 181:115-129.
45. Zhao LR, Berra HH, Duan WM, Singhal S, Mehta J, Apkarian AV, Kessler JA: Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats. Stroke 2007, 38:2804-2811.
46. Zhao LR, Singhal S, Duan WM, Mehta J, Kessler JA: Brain repair by hematopoietic growth factors in a rat model of stroke. Stroke 2007, 38:2584-2591.
47. Zhu W, Mao Y, Zhao Y, Zhou LF, Wang Y, Zhu JH, Zhu Y, Yang GY: Transplantation of vascular endothelial growth factor-transfected neural stem cells into the rat brain provides neuroprotection after transient focal cerebral ischemia. Neurosurgery 2005, 57:325-333; discussion 325-333.
48. Bang OY, Lee JS, Lee PH, Lee G: Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005, 57:874-882.
49. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY: A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 2010, 28:1099-1106.
50. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH: Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934.
51. Feany MB, Bender WW: A Drosophila model of Parkinson’s disease. Nature 2000, 404:394-398.
52. Dawson TM, Dawson VL: Molecular pathways of neurodegeneration in Parkinson’s disease. Science 2003, 302:819-822.
53. McKay R, Kittappa R: Will stem cell biology generate new therapies for Parkinson’s disease? Neuron 2008, 58:659-661.
54. Park HJ, Lee PH, Bang OY, Lee G, Ahn YH: Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson’s disease. J Neurochem 2008, 107:141-151.
55. Murrell W, Wetzig A, Donnellan M, Feron F, Burne T, Meedeniya A, Kesby J, Bianco J, Perry C, Silburn P, Mackay-Sim A: Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson’s disease. Stem Cells 2008, 26:2183-2192.
56. Yasuhara T, Matsukawa N, Hara K, Yu G, Xu L, Maki M, Kim SU, Borlongan CV: Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson’s disease. J Neurosci 2006, 26:12497-12511.
57. Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sanchez-Pernaute R, Bankiewicz K, McKay R: Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson’s disease. Nature 2002, 418:50-56.
58. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R: Neurons derived from
reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proc Natl Acad Sci USA 2008, 105:5856-5861.
59. Cai J, Yang M, Poremsky E, Kidd S, Schneider JS, Iacovitti L: Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells Dev 2010, 19:1017-1023.
60. Hideyama T, Yamashita T, Nishimoto Y, Suzuki T, Kwak S: Novel etiological and therapeutic strategies for neurodiseases: RNA editing enzyme abnormality in sporadic amyotrophic lateral sclerosis. J Pharmacol Sci 2010, 113:9-13.
61. Chi L, Ke Y, Luo C, Li B, Gozal D, Kalyanaraman B, Liu R: Motor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice. Stem Cells 2006, 24:34-43.
62. Corti S, Locatelli F, Papadimitriou D, Del Bo R, Nizzardo M, Nardini M, Donadoni C, Salani S, Fortunato F, Strazzer S, Bresolin N, Comi GP: Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Brain 2007, 130:1289-1305.
63. Magnus T, Carmen J, Deleon J, Xue H, Pardo AC, Lepore AC, Mattson MP, Rao MS, Maragakis NJ: Adult glial precursor proliferation in mutant SOD1G93A mice. Glia 2008, 56:200-208.
64. Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, Rothstein JD, Maragakis NJ: Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 2008, 11:1294-1301.
65. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K: Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321:1218-1221.
66. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N, Oggioni GD, Testa L, Fagioli F: Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci 2008, 265:78-83.
7. Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K, Testa L, Stecco A, Tarletti R, Miglioretti M, Fava E, Nasuelli N, Cisari C, Massara M, Vercelli R, Oggioni GD, Carriero A, Cantello R, Monaco F, Fagioli F: Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. Exp Neurol 2010, 223:229-237.
68. Weiner HL: The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 2009, 65:239-248.
69. Harrison DM, Calabresi PA: Promising treatments of tomorrow for multiple sclerosis. Ann Indian Acad Neurol 2009, 12:283-290.
70. Aharonowiz M, Einstein O, Fainstein N, Lassmann H, Reubinoff B, Ben-Hur T: Neuroprotective effect of transplanted human embryonic stem cell- derived neural precursors in an animal model of multiple sclerosis. PLoS One 2008, 3:e3145.
71. Pluchino S, Zanotti L, Brini E, Ferrari S, Martino G: Regeneration and repair in multiple sclerosis: the role of cell transplantation. Neurosci Lett 2009, 456:101-106.
72. Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Oyama Y, Russell EJ, Stern J, Muraro P, Rose J, Testori A, Bucha J, Jovanovic B, Milanetti F, Storek J, Voltarelli JC, Burns WH: Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol 2009, 8:244-253.
73. Sugarman J: Human stem cell ethics: beyond the embryo. Cell Stem Cell 2008, 2:529-533.
74. Hyun I, Lindvall O, Ahrlund-Richter L, Cattaneo E, Cavazzana-Calvo M, Cossu G, De Luca M, Fox IJ, Gerstle C, Goldstein RA, Hermeren G, High KA, Kim HO, Lee HP, Levy-Lahad E, Li L, Lo B, Marshak DR, McNab A, Munsie M, Nakauchi H, Rao M, Rooke HM, Valles CS, Srivastava A, Sugarman J, Taylor PL, Veiga A, Wong AL, Zoloth L, Daley GQ: New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 2008, 3:607-609.

Portal "Eternal youth" http://vechnayamolodost.ru

30.03.2012